John R. Moore, General Counsel at Edgewise Therapeutics, Inc. (EWTX), sold 4,730 shares at $9.76 ($46K) on 2022-10-03, disclosed to the SEC on 2022-10-05.
Scheduled sale ($46k) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EWTX | SELL | 2025-05-07 | $32K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.6M | — | Filing → |
| EWTX | SELL | 2024-05-03 | $37K | — | Filing → |